Literature DB >> 21603340

Spinal anesthesia for cesarean delivery in a patient receiving fondaparinux.

Jack B Rentz1, Stuart R Hart, Melissa Russo.   

Abstract

Fondaparinux sodium, a selective inhibitor of factor Xa, is a new anticoagulant being used for thromboprophylaxis in all patient populations. We outline a case of neuraxial anesthesia for cesarean delivery in a patient with recent fondaparinux use and discuss most recent literature recommendations.

Entities:  

Keywords:  Cesarean delivery; fondaparinux; neuraxial anesthesia; spinal

Year:  2011        PMID： 21603340      PMCID： PMC3096169     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


  5 in total

1.  Use of selective factor Xa inhibitors in special populations.

Authors:  Alexander G G Turpie
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2002-11

2.  Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.

Authors:  Andrea Gerhardt; Rainer Bernd Zotz; Marcus Stockschlaeder; Rüdiger Eberhard Scharf
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

3.  Epidural labor analgesia in a patient receiving fondaparinux.

Authors:  Leinani Aiono-Le Tagaloa; Brendan Carvalho
Journal:  Int J Obstet Anesth       Date:  2008-11-28       Impact factor: 2.603

Review 4.  Fondaparinux, the first selective factor Xa inhibitor.

Authors:  Alexander G G Turpie; Bengt I Eriksson; Michael R Lassen; Kenneth A Bauer
Journal:  Curr Opin Hematol       Date:  2003-09       Impact factor: 3.284

5.  Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.

Authors:  A Ekbatani; L R Asaro; A M Malinow
Journal:  Int J Obstet Anesth       Date:  2009-07-21       Impact factor: 2.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.